BRIDGEBIO PHARMA INC

CUSIP: 10806XAB8 Class: NOTE 2.500% 3/1

LAZARD ASSET MANAGEMENT LLC's Holding History (CIK: 0001207017)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 42,343,000 Value ($000) $800 Avg Close — Range —
Q3 2025
Shares 23,325,000 Value ($000) $328 Avg Close — Range —
Q2 2025
Shares 50,142,000 Value ($000) $63 Avg Close — Range —
Q1 2025
Shares 15,780,000 Value ($000) $18 Avg Close — Range —
Q4 2024
Shares 17,052,000 Value ($000) $18 Avg Close — Range —
Q3 2024
Shares 17,052,000 Value ($000) $18 Avg Close — Range —
Q2 2024
Shares 17,052,000 Value ($000) $17 Avg Close — Range —
Q1 2024
Shares 17,052,000 Value ($000) $18 Avg Close — Range —
Q4 2023
Shares 16,138,000 Value ($000) $20 Avg Close — Range —
Q3 2023
Shares 46,000 Value ($000) $0 Avg Close — Range —
Q2 2023
Shares 2,500,000 Value ($000) $2 Avg Close — Range —
Q1 2023
Shares 24,649,000 Value ($000) $18 Avg Close — Range —
Q4 2022
Shares 26,149,000 Value ($000) $12 Avg Close — Range —
Q3 2022
Shares 26,149,000 Value ($000) $15,658 Avg Close — Range —
Q2 2022
Shares 36,149,000 Value ($000) $20,019 Avg Close — Range —
Q1 2022
Shares 49,949,000 Value ($000) $29,170 Avg Close — Range —
Q4 2021
Shares 61,500,000 Value ($000) $45,338 Avg Close — Range —
Q3 2021
Shares 41,500,000 Value ($000) $57,362 Avg Close — Range —
Q2 2021
Shares 25,000,000 Value ($000) $41,125 Avg Close — Range —
Q1 2021
Shares 7,500,000 Value ($000) $12,408 Avg Close — Range —